Endocrine Abstracts

Background: In addition to glucose-lowering effects, Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) are the preferred treatment of choice in patients with heart failure due to their diuretic effects through glucosuria and natriuresis. However, there is limited data about urinary symptoms associated with SGLT2i use.Objectives: Low urinary tract symptoms such as increased urinary frequency, urgency, or incontinence due to SGLT2i use are not described i...

Background: William-Beuren region duplication syndrome (WBDS) is a rare multisystem disease caused by the gain on chromosome 7q and transmitted autosomal dominant, with approximately a population frequency of 1 in 13,000-20,000. The age of diagnosis is variable, but generally, it is diagnosed during childhood. It include endocrine (growth hormone deficiency) and non-endocrine (facial dysmorphology, cardiovascular problems, gastrointestinal and genitourinary problems, neurologi...